Navigation Links
Targeting the more lethal form of the cancer rhabdomyosarcoma
Date:5/25/2009

Rhabdomyosarcoma (RMS) is an aggressive muscle cancer that mostly affects children. The most common forms of RMS are embryonal rhabdomyosarcoma (ERMS) and alveolar rhabdomyosarcoma (ARMS). Although ARMS is less common than ERMS, it is associated with a much higher rate of mortality. A therapy tailored to the ARMS form of RMS is therefore badly needed. A team of researchers, at the Hospital for Sick Children, Toronto, and Monash Institute of Medical Research, Australia, has now provided hope that it might be possible to develop such a therapy by showing that the protein ILK promotes the growth of ARMS cells, whereas it suppresses the growth of ERMS cells.

The team, led by David Malkin and Gregory Hannigan, determined that the signaling protein JNK mediated these differing effects of ILK. Knocking down expression of ILK in ERMS cells induced activation of JNK and promoted tumor cell growth both in vitro and when the cells were transplanted into immunodeficient mice. Conversely, knocking down expression of ILK in ARMS cells abrogated both JNK signaling and tumor cell growth. Further analysis revealed that the protein product of the fusion gene that characterizes ARMS downregulated JNK1 expression, providing mechanistic insight into the opposing roles of ILK in ARMS and ERMS. The authors therefore suggest it should be possible to identify patients with ARMS who would benefit from an anticancer therapeutic that targets ILK.

In an accompanying commentary, Charles Keller and colleagues concur with the authors that targeting ILK might provide a therapeutic strategy tailored to the treatment of ARMS. However, they caution that further studies are needed, in part because of the high rate of misdiagnosis of ARMS versus ERMS.


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Edifecs(TM) and Axway Announce a Partnership Targeting Innovative HIPAA 5010 Migration Solutions.
2. Stem Cell Study Offers Hope for Targeting Tumors
3. Migraine prevention by targeting glutamate receptors?
4. Targeting oxidized cysteine through diet could reduce inflammation and lower disease risk
5. Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls
6. Targeting the protein AEG1 impairs human liver cancer growth in mice
7. Tobacco Companies Targeting Teens, Study Says
8. APIC 2009 Targeting Zero Initiative Offers Practical Tools, Evidence-Based Elimination Strategies to Prevent the Deadliest Healthcare-Associated Infections
9. Targeting Cancers Own Stem Cells to Fight Recurrence
10. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
11. Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Washington, D.C. (PRWEB) October 20, 2014 Zereana ... was crowned Mrs. Maryland 2014 on a platform to think ... battle scars, and uses her position to raise awareness about ... on awareness for breast cancer. You say the color pink ... “But I know for a fact that it has not ...
(Date:10/20/2014)... Diego, CA (PRWEB) October 20, 2014 AttorneyOne.com, ... all the latest information from the FDA on Sit ... on October 10 not to purchase or use Sit and ... Sit and Slim II is promoted as weight loss product ... Sibutramine, removed from the market in 2010 for safety reasons, ...
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
(Date:10/20/2014)... hard to imagine what it’s like to live without shoes, ... it’s a reality. And while new shoes are considered a ... barefoot on rocky terrain or sewage-lined streets just to collect ... , Buckner International's Shoes for Orphan Souls project ... encourage support for Air1 and while also providing new shoes ...
(Date:10/19/2014)... and Hastings, a Phoenix personal injury law firm with ... area and across Arizona reports record demand in 2014 ... Statistics have indicated a steady increase in automobile accidents ... and Hastings has seen a steady increase in the ... injured through no fault of their own that is ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
... OLIVE, N.J., Jan 12 InSet Technologies, an emerging ... targeted delivery of medication, announced today the closing of ... venture capital firm, led the round and was joined ... In conjunction with the financing, Kurt C. Wheeler of ...
... Dr. Schoenhaus Perform Foot Fat Pad Restoration on The Balancing ... with comfort and look great doing it" is more than ... experienced foot surgeon, she is a leading expert and innovator ... and legs, but as a woman, she understands the emotional ...
... business in Louisville, Business First of Louisville has named DRE a 2008 ... ... Inc., a premier international medical and surgical equipment supplier, has ... the Year. The award caps the most successful three-year period in DRE’s ...
... research tools to address large, unwarranted variations in project management, ... , ... Phoenixville, Pennsylvania (PRWEB) January ... large and unwarranted variations in corporate spending. As an example, ...
... a drug development company focusing on serious Central Nervous ... it held an initial closing of $2.9 million in ... use the funds for the clinical development of MCD-386, ... down disease progression and improving memory and cognition in ...
... Tenn., Jan. 11 HotHead Technologies, Inc., ... through,research-based technology, today announced it is working ... viable heat-sensing helmet insert, which can,detect potential ... News of their joint,development activities was officially ...
Cached Medicine News:Health News:InSet Technologies Completes $25 Million Financing 2Health News:Kay Renz Steps into PR Position for Cosmetic Foot, Leg and Vein Doctor, Jodi Schoenhaus 2Health News:Business First Selects DRE Medical Equipment as a Company of the Year 2Health News:Business First Selects DRE Medical Equipment as a Company of the Year 3Health News:Comparative Effectiveness Research Tools Address Variations in corporate spending 2Health News:Comparative Effectiveness Research Tools Address Variations in corporate spending 3Health News:New Venture Funding for Alzheimer's Disease Drug Developer 2Health News:HotHead Technologies Working with Schutt Sports to Develop 'Smart' Helmet 2Health News:HotHead Technologies Working with Schutt Sports to Develop 'Smart' Helmet 3
(Date:10/20/2014)... DIEGO , Oct. 20, 2014  AnaptysBio, ... of therapeutic antibodies, today announced the appointment of ... Officer. Dr. Londei will lead the preclinical and ... "We are pleased to welcome Dr. ... Hamza Suria , President and Chief Executive Officer ...
(Date:10/20/2014)... Oct. 20, 2014 Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, received official notification from the European ... another key patent supporting its iSONEP™ and ASONEP™ ... European patent No. 2087002, claims compositions of matter ... two lead compounds, iSONEP and ASONEP. Sonepcizumab is ...
(Date:10/20/2014)... , Oct. 20, 2014   Mary,s Medicinals ... for Caring, is a 4-Star Sponsor of Operation ... Veterans with unique products, programs and services to assist ... freedom. Key Facts: , An ... is a safe and effective treatment for pain, Post-traumatic ...
Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3
... N.J., Feb. 27, 2012    Octapharma USA has submitted ... the U.S. Food and Drug Administration (FDA) with ... fourth quarter of 2012. The FDA will evaluate ... preoperative or bleeding patients who require replacement of multiple plasma ...
... ST. LOUIS, Feb. 27, 2012 Stereotaxis, Inc. (NASDAQ: ... release financial results for the fourth quarter and full ... 2012 after the close of the U.S. financial markets.  ... at 4:30 p.m. Eastern Time that day to discuss ...
Cached Medicine Technology:Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events 2Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events 3Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012 2Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012 3
... Processing Video Camera is our new generation ... Image Processing (IP) technology, the IP 4.2 ... Exciting new features, enhanced image quality, and ... exceptional value. All IP 4.2 cameras are ...
... full lineup of high-powered Xenon, Metal ... optimal brightness in a durable, lightweight ... highest quality light guide cables, providing ... lightweight, durable design., Powerful illumination and ...
... Due to its design, this ... varieties of stone therapy in urinary ... primarily as a multipurpose lithotripter with ... and percutaneous nephrolithotomy. ,The basic system ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
Medicine Products: